Your browser doesn't support javascript.
loading
Impact of 11q Loss of Heterozygosity Status on the Response of High-Risk Neuroblastoma With MYCN Amplification to Neoadjuvant Chemotherapy.
Lu, Xian-Ying; Qu, Li-Jun; Duan, Xian-Lun; Zuo, Wei; Sai, Kai; Rui, Gang; Gong, Xian-Feng; Ding, Yi-Bo; Gao, Qun.
Afiliação
  • Lu XY; Department of General Surgery, Anhui Children's Hospital, Hefei, China.
  • Qu LJ; Department of Hematology and Oncology, Anhui Children's Hospital, Hefei, China.
  • Duan XL; Department of Thoracic Surgery, Anhui Children's Hospital, Hefei, China.
  • Zuo W; Department of Neonatal Surgery, Anhui Children's Hospital, Hefei, China.
  • Sai K; Department of General Surgery, Anhui Children's Hospital, Hefei, China.
  • Rui G; Department of General Surgery, Anhui Children's Hospital, Hefei, China.
  • Gong XF; Department of General Surgery, Anhui Children's Hospital, Hefei, China.
  • Ding YB; Department of General Surgery, Anhui Children's Hospital, Hefei, China.
  • Gao Q; Department of General Surgery, Anhui Children's Hospital, Hefei, China.
Front Pediatr ; 10: 898918, 2022.
Article em En | MEDLINE | ID: mdl-35757140
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article